Abstract
Background: Ischemia injury affects the recovery of liver allograft function. We propose a novel technique aimed at avoiding a second ischemic injury: transplanting an extended criteria donor (ECD) liver directly under normothermic machine perfusion (NMP) without recooling. We studied two cases to evaluate the efficacy and safety of this technique.
Methods: The perioperative characteristics and postoperative outcomes of two recipients of ECD livers were analyzed. Both transplantations were performed with continuous normothermic machine perfusion without recooling.
Result: In case 1, the cause of donor death was anoxia, and the donor liver had hypernatremia before procurement. The recipient was diagnosed with decompensated cirrhosis. His model for end-stage liver disease (MELD) score was 38. In case 2, the donor liver was from a donor after cardiac death (DCD), and the donor had elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels. The recipient was diagnosed with acute hepatic failure. His MELD score was 35. Both donor livers were maintained under NMP and then transplanted without recooling. The peak ALT and AST levels after surgery were 452 and 770 U/L in case 1 and 100 and 592 U/L in case 2. Neither early allograft dysfunction (EAD) nor primary graft non-function (PNF) was present in these two cases.
Conclusion: In conclusion, our results demonstrate that continuous NMP without recooling is efficacious and safe for LT with extended criteria donor livers. Further investigations of this technique will be performed to confirm these promising results.
Introduction
Liver transplantation (LT) is a successful treatment option for end-stage liver disease (ESLD) of various etiologies (). The 1-year survival rate after LT is ~90% thanks to tremendous improvements in surgical methods and immunosuppression (). Ischemia-reperfusion injury (IRI) constitutes an important cause of PNF, EAD, and biliary complications after LT (). Normothermic machine perfusion (NMP) is an organ preservation technique that entails continuous or pulsatile circulation of perfusate through the graft and has proven effective in ameliorating IRI (). In conventional NMP, the liver graft is usually flushed with cold solution before implantation, and IRI is still inevitable (). We propose a novel technique aimed at avoiding a second ischemic injury by transplanting ECD livers directly under NMP without recooling. We have reported on one patient who underwent this technique, who showed good recovery (). In this study, we report another two cases to further evaluate the efficacy and safety of this technique.
Materials and Methods
All the procedures were performed in accordance with the ethical standards of the responsible committee on human institutional and national experimentation and with the Helsinki Declaration of 1964 and its later revisions.
Two patients who had undergone OLT with continuous NMP without recooling were included in the study. The recipient pre-transplantation data and the perioperative data, including the perfusion parameters and postoperative complications, were assessed and analyzed.
Description of Continuous NMP Without Recooling and Implantation
Details about this technique have been described in previously published articles. Briefly, the donor liver was procured under a standard perfusion technique, and the organ was preserved in a University of Wisconsin (UW) solution prior to perfusion. Afterwards, the donor liver was reprocessed in NMP to 37°C following the flush of lactated Ringer's solution. After ligation of the cystic duct, a tube was placed in it to drain bile. The cannula was placed separately into the infrahepatic inferior vena cava (IHIVC), portal vein (PV) via an interposition vascular graft (the donor iliac artery), and the gastroduodenal artery (GDA), respectively, then connected to a liver assist device for perfusion. The perfusate is described in Table 1. Electrolyte balance and acid-base equilibrium were adjusted and maintained throughout the perfusion process. Perfusion was continuous from the time of preservation to the reperfusion.
Table 1
| Components | |
|---|---|
| Crossed-matched leucocyte-depleted washed red cells | 8 U |
| Gelofusine® | 800 ml |
| 5% sodium bicarbonate | 150 ml |
| Heparin | 37,500 U |
| 10% calcium gluconate | 30 ml |
| 25% magnesium sulfate | 2 ml |
| Methylprednisolone | 500 mg |
| Compound Amino Acid Injection | 250 ml |
| Imipenem cilastatin | 0.5 g |
| Metronidazole | 100 ml |
The components of the perfusate solution.
After dissection of the diseased liver, the donor liver was transplanted with an undergoing NMP circuit. We first anastomosed the donor suprahepatic inferior vena cava (SHIVC) and the recipient counterpart in an end-to-end fashion. Subsequently, PV and HA were anastomosed with the donor's counterpart in an end-to-end fashion. During the anastomosis, the blood supply was not stopped. Afterwards, the clamps on the recipient's PV and HA were removed to restore the blood supply to the donor liver soon after NMP was stopped, after removal of the HA and PV cannula (Figure 1). The IHIVC cannula was then removed, and the IHIVC was anastomosed in an end-to-end fashion. After removal of the drainage tube, the common bile duct was anastomosed end-to-end.
Figure 1
Posttransplant Care
After the transplantation, all patients were transferred to the intensive care unit with the endotracheal tube. After the tubes were removed, the patients were transferred to the general ward for further care. Biomedical values including regular blood test, transaminase, and bilirubin were tested and documented every day in the first week. Routine Doppler ultrasound of the liver graft blood flow and biliary tract was performed once every 2 days for 7 days. The immunosuppressive regimen was similar for all patients and included tacrolimus and mycophenolate mofetil. Basiliximab (20 mg) was administered intraoperatively before closing the abdomen and the 4th day postoperation by intravenous pump for induction immunotherapy. The blood levels of tacrolimus were 8–12 ng/ml in the first month, followed by 4–8 ng/ml thereafter.
Results
Data of these two cases are presented in Table 2. In case 1, the serum AST, ALT, and total bilirubin (Tbil) levels of the donor before procurement were 56.8 U/L, 26.2 U/L, and 10.7 μmol/L, respectively. Hypernatremia (sodium, 165 mmol/L), anoxia as the cause of death, and a long cold ischemia time of more than 8 h were the risk factors for failed liver transplantation. In case 2, the AST, ALT, and TBil levels of the donor were 163 U/L, 151 U/L, and 6.2 μmol/L, respectively. Risk factors were as follows: donor after cardiac death (DCD), anoxia as the cause of death, and a cold ischemia time of more than 10 h. All risk factors made these two donors ECDs.
Table 2
| Donor 1 | Donor 2 | |
|---|---|---|
| Donor type | DBD | DCD |
| Sodium (mmol/L) | 165 | 150 |
| Potassium (mmol/L) | 3.66 | 3.50 |
| Hemoglobin (g/L) | 114 | 79 |
| AST(U/L) | 56.8 | 163 |
| ALT(U/L) | 26.2 | 151 |
| GGT(U/L) | 27 | 31 |
| Bilirubin (mmol/L) | 10.7 | 6.2 |
| Anhepatic time, min | 86 | 51 |
| CIT, h | 8 | 10 |
| WIT, min | 0 | 8 |
| Patient 1 | Patient 2 | |
| MELD | 38 | 35 |
| Preoperative AST(U/L) | 11 | 50 |
| Preoperative ALT(U/L) | 39 | 35 |
| Preoperative Bilirubin (mmol/L) | 152.8 | 440.8 |
| Total operation time (mins) | 470 | 460 |
| Anhepatic time (mins) | 55 | 51 |
| Intraoperative transfusions (U) | 26 | 20 |
| Blood loss (ml) | 6,000 | 4,000 |
| ICU length-of-stay (h) | 105 | 216 |
| Peak AST(U/L) | 770 | 592 |
| Peak ALT(U/L) | 452 | 100 |
| INR on POD 7 | 1.35 | 1.23 |
| Bilirubin (mmol/L) on POD7 | 86.8 | 78.9 |
| EAD | 0 | 0 |
| PNF | 0 | 0 |
| Biliary anastomotic strictures | 0 | 0 |
| Hepatic artery complications | 0 | 0 |
| Acute kidney injury | 0 | 1 |
Perioperative data of 2 patients with continuous NMP without re-cooling.
DBD, Donor after brain death; DCD, Donor after cardiac death; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase; GGT, γ-glutamyl transpeptidase; CIT, Cold ischemia time; WIT, Warm ischemia time; MELD, Model for end-stage liver diseases; ICU, Intensive care unit; INR, International normalized ratios; EAD, Early allograft dysfunction; PNF, Primary nonfunction; POD, postoperative day.
The recipient patient in case 1 was diagnosed with hepatitis B virus-associated (HBV) decompensated cirrhosis. He had a history of esophageal and gastric variceal bleeding and abdominal bleeding. His serum AST, ALT, and Tbil levels were 11 U/L, 39 U/L, and 152.8 μmol/L, respectively. His MELD score was 38. The recipient in case 2 was diagnosed with acute hepatic failure and hepatic encephalopathy. He had a history of cerebral infarction, hypertension, and HBV infection. His AST, ALT, and Tbil levels were 50 U/L, 35 U/L, and 440.8 μmol/L, respectively. His MELD score was 38.
NMP was performed for a total of 7 h for each donor liver (Figure 2). During the perfusion process, the electrolyte balance and acid-base equilibrium were adjusted and maintained. The pH during perfusion was adjusted and maintained at 7.37 and 7.42 in cases 1 and 2, respectively. The lactate concentration dropped significantly, from 9.9 to 2.4 mmol/L after 80 min of perfusion in case 1 and from 9.2 to 1.4 mmol/L after 80 min of perfusion in case 2. The concentrations of calcium and sodium remained stable in both cases. The anhepatic time was 55 and 51 min in cases 1 and 2, respectively.
Figure 2
Postoperative data are presented in Table 2. The intensive care unit (ICU) stay times were 105 and 216 h, respectively. The maximal ALT and AST were 452 and 770 U/L in case 1 and 100 and 592 U/L in case 2, respectively. The international normalized ratio (INR) and TBil on postoperative day (POD) 7 were 1.35 and 86.8 mmol/L in case 1, respectively, and 1.23 and 78.9 mmol/L in case 2 (Figure 3). Neither EAD nor PNF was presented in either case. Patient 2 suffered from acute kidney injury (AKI).
Figure 3
Discussion
In conventional LT, cryopreservation can reduce the physiological metabolism of cells but cannot slow down the damage to cell integrity (). IRI represents one of the major challenges during liver surgery and LT. To minimize the risk of PNF or EAD caused by IRI, we designed a novel method called continuous NMP without recooling for ECD livers. A case report on the feasibility of avoiding cooling was authored by Fabrizio et al. (). However, they do not describe the details of the specific procedures. Ju et al. were the first to describe how to avoid a second cooling before implantation and proved that doing so helps reduce the risk of PNF or EAD (). In this study, we report two cases of LT following this technique.
ECD livers are thought to be of lower-than-average quality and to be associated with poorer postoperative outcomes (). Maring et al. suggested that ECD livers are associated with older donor age, longer warm ischemia time, moderate or severe microvascular steatosis, and HBsAg positivity (). The review by Vodkin et al. noted that ECD livers are correlated with older donor age, steatosis, DCD, and donors with an increased risk of disease transmission (). In our study, both donor livers had several risk factors, confirming that they were ECD livers. They were not suited for transplantation with conventional cold preservation. Tchilikidi et al. suggested that ECD transplantation required measures for graft preservation and assessment (). NMP provides an effective method for salvaging ECD organs. Davide et al. retrospectively studied 34 transplantations of DCD donors using NMP and showed that it would be feasible for DCD LT (). The prospective clinical trial of Otto et al. reported that NMP was a safe option for risky donor livers and increased the number of available donor livers (). Nevertheless, current NMP techniques have potential problems and need innovation. Our novel technique is designed to solve this problem: during preservation and implantation, the blood supply is not stopped. In our cases, the laboratory test results fell from above the normal ranges to within the normal ranges within 1 week. Neither EAD nor PNF was presented. However, further randomized clinical trial (RCT) data are needed to confirm its safety and efficacy.
The limitations of our study are as follows. First, the preservation (the establishment of portal interposition vascular graft and the connection of cannulas) and the implantation are complex and need to be further modified. In addition, its effectiveness needs to be proven in a RCT.
In conclusion, our results demonstrate that continuous NMP without recooling is efficacious and safe for LT with extended criteria donor livers.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.
Ethics statement
The studies involving human participants were reviewed and approved by Institutional Ethics Committee for Clinical Research and Animal Trials of the First Affiliated Hospital of Sun Yat-sen University. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.
Author contributions
WJ and MC: conceptualization. ZG and XHe: methodology. ZC, XHo, TW, and SH: writing–original draft. YM, CH, YG, and QZ: data collection. MC: writing—review and editing. WJ: supervision. XHe: project administration. WJ, MC, and XHe: funding acquisition. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by the National Natural Science Foundation of China (81401324 and 81770410), Guangdong Basic and Applied Basic Research Foundation (2020A1515011557, 2020A1515010903), Science and Technology Planning Project of Guangdong Province (2016A020215048), Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology (2020B1212060026), and Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation) (2015B050501002), China.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- AKI
acute kidney injury
- AST
aspartate transaminase
- ALT
alanine transaminase
- DBD
donor after brain death
- DCD
donor after cardiac death
- EAD
early allograft dysfunction
- ECD
extended criteria donor
- ESLD
end-stage liver disease
- GDA
gastroduodenal artery
- HBV
hepatitis B virus
- HA
hepatic artery
- ICU
intensive care unit
- IRI
ischemia-reperfusion injury
- INR
international normalized ratio
- IHIVC
infrahepatic inferior vena cava
- LT
liver transplantation
- MELD
model for end-stage liver disease
- NMP
normothermic machine perfusion
- PV
portal vein
- PNF
primary graft non-function
- POD
postoperative day
- RCT
randomized clinical trials
- SHIVC
suprahepatic inferior vena cava
- Tbil
total bilirubin
- UW
University of Wisconsin.
Abbreviations
References
1.
Meirelles JuniorRFSalvalaggioPRezendeMBEvangelistaASGuardiaBDet al. Liver transplantation: history, outcomes and perspectives. Einstein. (2015) 13:149–52. 10.1590/S1679-45082015RW3164
2.
MorrisPJ. Transplantation–a medical miracle of the 20th century. N Engl J Med. (2004) 351:2678–80. 10.1056/NEJMp048256
3.
Schlegel A Dutkowski P: Impact of machine perfusion on biliary complications after liver transplantation. Int J Mol Sci. (2018) 19:E3567. 10.3390/ijms19113567
4.
di FrancescoFPaganoDMartucciGGruttadauria S: Normothermic machine perfusion using an air/oxygen mixer for reconditioning a liver from a marginal brain death donor. Artif Organs. (2017) 41:E66–8. 10.1111/aor.12964
5.
HoubenPManziniGKremerMArendJBerlakovichGAKlarEet al. Graft rinse prior to reperfusion in liver transplantation: literature review and online survey within the Eurotransplant community. Transplant Int. (2015) 28:1291–8. 10.1111/tri.12631
6.
JuW CZZhaoQZhangYHuangCWangLZhuCet al. Non-re-cooling implantation of marginal liver graft after machine perfusion: report of a case. Ann Transl Med. (2020) 8:1465. 10.21037/atm-20-2774
7.
BricenoJMarchalTPadilloJSolorzanoGPeraC. Influence of marginal donors on liver preservation injury. Transplantation. (2002) 74:522–6. 10.1097/00007890-200208270-00015
8.
di FrancescoFPaganoDMartucciGCintorinoDGruttadauriaS. Normothermic machine perfusion in liver transplantation: feasibility and promise of avoiding recooling before engrafting. Liver Transplantation. (2019) 25:1113–7. 10.1002/lt.25473
9.
DurandFRenzJFAlkoferBBurraPClavienPAPorteRJet al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transplantation. (2008) 14:1694–707. 10.1002/lt.21668
10.
MaringJKKlompmakerIJZwavelingJHKranenburgKTen VergertEMSlooffMJ. Poor initial graft function after orthotopic liver transplantation: can it be predicted and does it affect outcome? An analysis of 125 adult primary transplantations. Clin Transplantation. (1997) 11(5 Pt 1):373–9.
11.
VodkinIKuoA. Extended criteria donors in liver transplantation. Clinics Liver Dis. (2017) 21:289–301. 10.1016/j.cld.2016.12.004
12.
TchilikidiKY. Liver graft preservation methods during cold ischemia phase and normothermic machine perfusion. World J Gastrointestinal Surg. (2019) 11:126–42. 10.4240/wjgs.v11.i3.126
13.
GhinolfiDDondossolaDRrekaELonatiCPezzatiDCacciatoinsillaAet al. Sequential use of normothermic regional and ex situ machine perfusion in donation after circulatory death liver transplant. Liver Transplantation. (2020) 27:385–402. 10.1002/lt.25899
14.
van LeeuwenOBde VriesYFujiyoshiMNijstenMWNUbbinkRPelgrimGJet al. Transplantation of high-risk donor livers after ex situ resuscitation and assessment using combined hypo- and normothermic machine perfusion: a prospective clinical trial. Annals Surg. (2019) 270:906–14. 10.1097/SLA.0000000000003540
Summary
Keywords
continuous normothermic machine perfusion, extended criteria donor liver, early allograft dysfunction, donor after cardiac death, allograft
Citation
Chen Z, Hong X, Huang S, Wang T, Ma Y, Guo Y, Huang C, Zhao Q, Guo Z, He X, Ju W and Chen M (2021) Continuous Normothermic Machine Perfusion for Renovation of Extended Criteria Donor Livers Without Recooling in Liver Transplantation: A Pilot Experience. Front. Surg. 8:638090. doi: 10.3389/fsurg.2021.638090
Received
05 December 2020
Accepted
15 April 2021
Published
24 May 2021
Volume
8 - 2021
Edited by
Peter Schemmer, Medical University of Graz, Austria
Reviewed by
Bassem Soliman Hegab, National Liver Institute, Egypt; Cristiano Quintini, Cleveland Clinic, United States
Updates
Copyright
© 2021 Chen, Hong, Huang, Wang, Ma, Guo, Huang, Zhao, Guo, He, Ju and Chen.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiaoshun He gdtrc@163.comMaogen Chen chenmg3@mail.sysu.edu.cnWeiqiang Ju weiqiangju@163.com
This article was submitted to Visceral Surgery, a section of the journal Frontiers in Surgery
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.